PAVmed (PAVM) director granted 150,000 restricted shares

Sundeep Agrawal, a director of PAVmed Inc. (PAVM), reported an acquisition of 150,000 shares of common stock on 09/30/2025 via restricted stock granted under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan.

Rhea-AI Filing Summary

Sundeep Agrawal, a director of PAVmed Inc. (PAVM), reported an acquisition of 150,000 shares of common stock on 09/30/2025 via restricted stock granted under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan. The shares carry a single vesting date of May 20, 2028 and are subject to forfeiture if the required service period is not completed. Following the grant, the reporting person’s beneficial ownership is reported as 162,195 shares. The Form 4 was signed by power of attorney on 10/02/2025.

Positive

• 150,000 restricted shares granted to a company director, aligning management incentives
• Reporting discloses a clear vesting schedule: single vesting date of May 20, 2028
• Beneficial ownership disclosed as 162,195 shares after the transaction

Negative

• The granted shares are subject to forfeiture until the May 20, 2028 vesting date
• Transaction price reported as $0, indicating a grant rather than a market purchase

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider Agrawal Sundeep

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	150,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 162,195 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PAVmed (PAVM) director Sundeep Agrawal acquire?

The Form 4 reports a grant of 150,000 restricted shares of PAVmed common stock on 09/30/2025.

When do the restricted shares granted to Sundeep Agrawal vest?

The restricted shares have a single vesting date of May 20, 2028 and are subject to forfeiture if the service period is not completed.

How many PAVmed shares does the reporting person beneficially own after the grant?

The Form 4 reports 162,195 shares beneficially owned following the reported transaction.

What was the reported price for the restricted stock grant?

The restricted stock is reported with a price of $0, indicating it was granted rather than purchased.

Who signed the Form 4 and when was it filed?

The filing bears a signature by power of attorney (Michael A. Gordon) dated 10/02/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Agrawal Sundeep

(Last) (First) (Middle)

360 MADISON AVENUE, 25TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		150,000(1)	A	$0(1)	162,195	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon, by power of attorney	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.